UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sustained virological response following extremely short antiviral treatment in selected HCV carriers with persistently normal ALT

Digestive and liver disease, 2010-10, Vol.42 (10), p.745-745

2010

Volltextzugriff (PDF)

Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma

Journal of viral hepatitis, 2012-04, Vol.19 (4), p.229-235

2012

Volltextzugriff (PDF)

Vaccine-escape HBsAg mutants circulating among genotype D HBV-infected patients correlate with atypical serological profiles, high viremia and transaminases: Potential impact on vaccination strategies

Digestive and liver disease, 2016-02, Vol.48, p.e5-e6

2016

Volltextzugriff (PDF)

Review article: management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activity

Alimentary Pharmacology and Therapeutics, 2006-10, Vol.24 (8), p.1133-1149

2006

Volltextzugriff (PDF)

First-Line Liver Resection and Salvage Liver Transplantation Are Increasing Therapeutic Strategies for Patients With Hepatocellular Carcinoma and Child A Cirrhosis

Transplantation proceedings, 2007-07, Vol.39 (6), p.1857-1860

2007

Volltextzugriff (PDF)

Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study

Journal of viral hepatitis, 2011-06, Vol.18 (6), p.393-399

2011

Volltextzugriff (PDF)

HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy

Journal of hepatology, 2003-04, Vol.38 (4), p.529-532

Puoti, Claudio

2003

Volltextzugriff (PDF)

Clinical management of HCV carriers with normal aminotransferase levels

Digestive and liver disease, 2003-05, Vol.35 (5), p.362-369

2003

Volltextzugriff (PDF)

Steatosis and portal hypertension

European review for medical and pharmacological sciences, 2005-09, Vol.9 (5), p.285

2005

Volltextzugriff (PDF)

Etiology, management, and outcome of the Budd-Chiari syndrome

Annals of internal medicine, 2009-08, Vol.151 (3), p.167

2009

Volltextzugriff (PDF)

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow‐up study

Hepatology (Baltimore, Md.), 2010-01, Vol.51 (1), p.210-218

2010

Volltextzugriff (PDF)

Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?

Digestive and Liver Disease, 2000-10, Vol.32 (7), p.634-643

2000

Volltextzugriff (PDF)

F.N.13 PREVALENCE OF SPONTANEOUS HEPATIC-TO-HEPATIC VENOUS SHUNTS IN CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION

Digestive and liver disease, 2010, Vol.42, p.S37-S38

2010

Volltextzugriff (PDF)

DOES THE DEGREE OF PORTAL HYPERTENSION CORRELATE WITH THE SEVERITY OF LIVER CIRRHOSIS?

Digestive and liver disease, 2009, Vol.41, p.S103-S103

2009

Volltextzugriff (PDF)

Peripheral blood serum markers for apoptosis and liver fibrosis: Are they trustworthy indicators of liver realness?

Digestive and liver disease, 2008-06, Vol.40 (6), p.441-445

2008

Volltextzugriff (PDF)

Quantitation of tissue polypeptide antigen (TPA) in hepatic vein Blood and systemic circulation in patients with cirrhosis and HCC

Digestive and liver disease, 2009, Vol.41 (5), p.A9-A10

2009

Volltextzugriff (PDF)

826 ANTIVIRAL TREATMENT OF HCV CARRIERS WITH NORMAL ALT

Journal of hepatology, 2008, Vol.48, p.S309-S310

2008

Volltextzugriff (PDF)

survivin-IgM immuno complex: A novel candidate biomarker of cirrhosis to monitor patients progression towards hepatocellular carcinoma

Digestive and liver disease, 2009, Vol.41 (5), p.A13-A13

2009

Volltextzugriff (PDF)

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

BMC infectious diseases, 2018-05, Vol.18 (1), p.223-223, Article 223

2018

Volltextzugriff (PDF)

Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)

Journal of hepatology, 2002-07, Vol.37 (1), p.117-123

2002

Volltextzugriff (PDF)

OC3.10.3 ANTIVIRAL TREATMENT OF HCV CARRIERS WITH NORMAL ALT

Digestive and liver disease, 2008, Vol.40, p.S66-S66

2008

Volltextzugriff (PDF)

Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study

Future oncology (London, England), 2013-02, Vol.9 (2), p.283-294

2013

Volltextzugriff (PDF)

Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency

Digestive and liver disease, 2014-09, Vol.46 (9), p.826-832

2014

Volltextzugriff (PDF)

Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels

Hepatology (Baltimore, Md.), 1997-12, Vol.26 (6), p.1393-1398

1997

Volltextzugriff (PDF)

HCV carriers with normal ALT: healthy people or patients with chronic hepatitis? The Italian study of the asymptomatic C carriers (ISACC)

Journal of hepatology, 2001-04, Vol.34, p.140

Puoti, C

2001

Volltextzugriff (PDF)

1 – 25 von 395

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(378)
Mit Volltextzugriff
(345)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Sustained virological response following extremely short antiviral treatment in selected HCV carriers with persistently normal ALT

Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma

Vaccine-escape HBsAg mutants circulating among genotype D HBV-infected patients correlate with atypical serological profiles, high viremia and transaminases: Potential impact on vaccination strategies

Review article: management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activity

First-Line Liver Resection and Salvage Liver Transplantation Are Increasing Therapeutic Strategies for Patients With Hepatocellular Carcinoma and Child A Cirrhosis

Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study

HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy

Clinical management of HCV carriers with normal aminotransferase levels

Steatosis and portal hypertension

Etiology, management, and outcome of the Budd-Chiari syndrome

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow‐up study

Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?

F.N.13 PREVALENCE OF SPONTANEOUS HEPATIC-TO-HEPATIC VENOUS SHUNTS IN CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION

DOES THE DEGREE OF PORTAL HYPERTENSION CORRELATE WITH THE SEVERITY OF LIVER CIRRHOSIS?

Peripheral blood serum markers for apoptosis and liver fibrosis: Are they trustworthy indicators of liver realness?

Quantitation of tissue polypeptide antigen (TPA) in hepatic vein Blood and systemic circulation in patients with cirrhosis and HCC

826 ANTIVIRAL TREATMENT OF HCV CARRIERS WITH NORMAL ALT

survivin-IgM immuno complex: A novel candidate biomarker of cirrhosis to monitor patients progression towards hepatocellular carcinoma

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)

OC3.10.3 ANTIVIRAL TREATMENT OF HCV CARRIERS WITH NORMAL ALT

Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study

Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency

Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels

HCV carriers with normal ALT: healthy people or patients with chronic hepatitis? The Italian study of the asymptomatic C carriers (ISACC)

Suchergebnisse filtern